| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 35 | +71.43% | -0.06% | -0.95% | +0.89% | +0.56% | 0.85 |
| 14d | 35 | +48.57% | +0.52% | -1.67% | +2.19% | +2.65% | 1.44 |
| 30d | 35 | +65.71% | -0.20% | -2.14% | +1.95% | +3.72% | 0.77 |
| 60d | 35 | +80.00% | -7.89% | -0.88% | -7.01% | -8.80% | -2.52 |
| 90d | 35 | +57.14% | -1.40% | -1.03% | +0.86% | -1.71% | 0.20 |
| 180d | 35(1 pending) | +79.41% | -8.81% | -1.65% | -7.16% | -9.11% | -1.31 |
| 1y | 35(2 pending) | +63.64% | -8.82% | +10.08% | -18.90% | -37.06% | -3.14 |
| 2y | 35(2 pending) | +75.76% | -13.73% | +30.02% | -43.74% | -48.39% | -6.55 |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ARVN ARVINAS, INC. | PURCHASEGRANT Stock grant | 15,527 | — | — | 111,548 | Jun 24, 2026 | Jun 26, 2026 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASEGRANT Stock grant | 22,714 | — | — | 22,714 | Jun 24, 2026 | Jun 26, 2026 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASEGRANT Stock grant | 13,000 | — | — | 13,000 | Jun 5, 2026 | Jun 9, 2026 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASE | 20,000 | $13.40 | $268.1K | 96,021 | Mar 6, 2026 | Mar 9, 2026 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASE | 30,000 | $7.57 | $227.0K | 76,021 | Sep 22, 2025 | Sep 24, 2025 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASEGRANT Stock grant | 23,105 | — | — | 23,105 | Jun 25, 2025 | Jun 27, 2025 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASEGRANT Stock grant | 16,025 | — | — | 46,021 | Jun 25, 2025 | Jun 27, 2025 ↗ | View → |
| HOWL WEREWOLF THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 27,000 | — | — | 27,000 | Jun 12, 2025 | Jun 13, 2025 ↗ | View → |
| CRSP CRISPR THERAPEUTICS AG | PURCHASEGRANT Stock grant | 13,000 | — | — | 13,000 | Jun 5, 2025 | Jun 6, 2025 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASEGRANT Stock grant | 9,070 | — | — | 9,070 | May 29, 2024 | May 31, 2024 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASEGRANT Stock grant | 5,899 | — | — | 29,996 | May 29, 2024 | May 31, 2024 ↗ | View → |
| HOWL WEREWOLF THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 17,500 | — | — | 17,500 | May 24, 2024 | May 24, 2024 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 17,000 | — | — | 34,836 | Feb 7, 2024 | Feb 9, 2024 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE10b5-1 10b5-1 plan | 52,855 | $18.27 | $965.4K | 17,836 | Aug 9, 2023 | Aug 10, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE | 52,855 | — | — | 0 | Aug 9, 2023 | Aug 10, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE | 52,855 | $8.77 | $463.5K | 70,691 | Aug 9, 2023 | Aug 10, 2023 ↗ | View → |
| HOWL WEREWOLF THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 13,200 | — | — | 13,200 | Jun 21, 2023 | Jun 23, 2023 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASEGRANT Stock grant | 12,787 | — | — | 12,787 | Jun 15, 2023 | Jun 20, 2023 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASEGRANT Stock grant | 4,121 | — | — | 24,097 | Jun 15, 2023 | Jun 20, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE | 24,582 | — | — | 0 | Jun 9, 2023 | Jun 9, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE | 28,273 | — | — | 0 | Jun 9, 2023 | Jun 9, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE | 24,582 | $6.38 | $156.8K | 42,418 | Jun 9, 2023 | Jun 9, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE | 28,273 | $8.77 | $248.0K | 70,691 | Jun 9, 2023 | Jun 9, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE10b5-1 10b5-1 plan | 28,273 | $21.18 | $598.8K | 17,836 | Jun 9, 2023 | Jun 9, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE10b5-1 10b5-1 plan | 24,582 | $21.18 | $520.6K | 46,109 | Jun 9, 2023 | Jun 9, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE | 52,855 | — | — | 0 | May 9, 2023 | May 10, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE10b5-1 10b5-1 plan | 52,855 | $21.41 | $1.13M | 17,836 | May 9, 2023 | May 10, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE | 52,855 | $6.38 | $337.2K | 70,691 | May 9, 2023 | May 10, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE10b5-1 10b5-1 plan | 52,855 | $19.53 | $1.03M | 17,836 | Apr 10, 2023 | Apr 12, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE | 52,855 | — | — | 0 | Apr 10, 2023 | Apr 12, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE | 52,855 | $6.38 | $337.2K | 70,691 | Apr 10, 2023 | Apr 12, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 52,854 | $22.53 | $1.19M | 17,836 | Mar 13, 2023 | Mar 14, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 52,854 | — | — | 0 | Mar 13, 2023 | Mar 14, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE President, Head of R&D | 52,854 | $6.38 | $337.2K | 70,690 | Mar 13, 2023 | Mar 14, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 52,854 | — | — | 0 | Feb 6, 2023 | Feb 8, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 52,854 | $26.83 | $1.42M | 17,836 | Feb 6, 2023 | Feb 8, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE President, Head of R&D | 52,854 | $6.38 | $337.2K | 70,690 | Feb 6, 2023 | Feb 8, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 32,000 | $28.55 | $913.6K | 32,000 | Feb 2, 2023 | Feb 3, 2023 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE President, Head of R&D | 59,649 | $10.90 | $650.2K | 77,485 | Sep 20, 2022 | Sep 21, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 59,649 | $23.25 | $1.39M | 17,836 | Sep 20, 2022 | Sep 21, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 59,649 | — | — | 0 | Sep 20, 2022 | Sep 21, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 114,339 | $23.03 | $2.63M | 17,836 | Sep 19, 2022 | Sep 21, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 114,339 | — | — | 0 | Sep 19, 2022 | Sep 21, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE President, Head of R&D | 114,339 | $10.90 | $1.25M | 132,175 | Sep 19, 2022 | Sep 21, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 71,966 | $23.22 | $1.67M | 17,836 | Sep 16, 2022 | Sep 16, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE President, Head of R&D | 53,034 | $10.90 | $578.1K | 70,870 | Sep 16, 2022 | Sep 16, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 53,034 | $23.22 | $1.23M | 17,836 | Sep 16, 2022 | Sep 16, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 71,966 | — | — | 0 | Sep 16, 2022 | Sep 16, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 53,034 | — | — | 0 | Sep 16, 2022 | Sep 16, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE President, Head of R&D | 71,966 | $7.20 | $518.2K | 89,802 | Sep 16, 2022 | Sep 16, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 66,775 | $24.20 | $1.62M | 17,836 | Sep 15, 2022 | Sep 16, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE President, Head of R&D | 66,775 | $7.20 | $480.8K | 84,611 | Sep 15, 2022 | Sep 16, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 66,775 | — | — | 0 | Sep 15, 2022 | Sep 16, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 87,645 | $23.80 | $2.09M | 17,836 | Sep 14, 2022 | Sep 16, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 87,645 | — | — | 0 | Sep 14, 2022 | Sep 16, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE President, Head of R&D | 87,645 | $7.20 | $631.0K | 105,481 | Sep 14, 2022 | Sep 16, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE President, Head of R&D | 62,292 | $7.20 | $448.5K | 80,128 | Jul 1, 2022 | Jul 5, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 62,292 | $19.00 | $1.18M | 17,836 | Jul 1, 2022 | Jul 5, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 62,292 | — | — | 0 | Jul 1, 2022 | Jul 5, 2022 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASEGRANT Stock grant | 10,192 | — | — | 10,192 | Jun 16, 2022 | Jun 21, 2022 ↗ | View → |
| HOWL WEREWOLF THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 11,600 | — | — | 11,600 | Jun 1, 2022 | Jun 3, 2022 ↗ | View → |
| ARVN ARVINAS, INC. | SALE | 7,104 | $66.07 | $469.4K | 30,730 | Apr 14, 2022 | Apr 18, 2022 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASE | 16,188 | $16.00 | $259.0K | 40,936 | Apr 14, 2022 | Apr 18, 2022 ↗ | View → |
| ARVN ARVINAS, INC. | SALE | 16,188 | — | — | 494 | Apr 14, 2022 | Apr 18, 2022 ↗ | View → |
| ARVN ARVINAS, INC. | SALE | 10,754 | $67.03 | $720.9K | 19,976 | Apr 14, 2022 | Apr 18, 2022 ↗ | View → |
| ARVN ARVINAS, INC. | SALE | 3,102 | $65.24 | $202.4K | 37,834 | Apr 14, 2022 | Apr 18, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 3,128 | — | — | 0 | Apr 4, 2022 | Apr 13, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 3,128 | — | — | 0 | Apr 4, 2022 | Apr 5, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE President, Head of R&D | 3,128 | $10.90 | $34.1K | 20,964 | Apr 4, 2022 | Apr 5, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 3,128 | $18.29 | $57.2K | 17,836 | Apr 4, 2022 | Apr 5, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE President, Head of R&D | 3,128 | $7.20 | $22.5K | 20,964 | Apr 4, 2022 | Apr 13, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 70,545 | — | — | 0 | Apr 1, 2022 | Apr 13, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 24,500 | $17.44 | $427.3K | 17,836 | Apr 1, 2022 | Apr 5, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE President, Head of R&D | 70,545 | $10.90 | $768.9K | 88,381 | Apr 1, 2022 | Apr 5, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 70,545 | $17.46 | $1.23M | 17,836 | Apr 1, 2022 | Apr 5, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 70,545 | — | — | 0 | Apr 1, 2022 | Apr 5, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE President, Head of R&D | 6,000 | $17.44 | $104.6K | 42,336 | Apr 1, 2022 | Apr 5, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE President, Head of R&D | 70,545 | $7.20 | $507.9K | 88,381 | Apr 1, 2022 | Apr 13, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 160,000 | $15.79 | $2.53M | 160,000 | Feb 2, 2022 | Feb 3, 2022 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASE | 16,188 | $16.00 | $259.0K | 45,708 | Jan 14, 2022 | Jan 19, 2022 ↗ | View → |
| ARVN ARVINAS, INC. | SALE | 9,919 | $64.33 | $638.1K | 35,789 | Jan 14, 2022 | Jan 19, 2022 ↗ | View → |
| ARVN ARVINAS, INC. | SALE | 16,188 | — | — | 16,682 | Jan 14, 2022 | Jan 19, 2022 ↗ | View → |
| ARVN ARVINAS, INC. | SALE | 2,108 | $67.69 | $142.7K | 24,748 | Jan 14, 2022 | Jan 19, 2022 ↗ | View → |
| ARVN ARVINAS, INC. | SALE | 5,100 | $67.28 | $343.1K | 26,856 | Jan 14, 2022 | Jan 19, 2022 ↗ | View → |
| ARVN ARVINAS, INC. | SALE | 3,833 | $65.24 | $250.1K | 31,956 | Jan 14, 2022 | Jan 19, 2022 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE Chief Executive Officer | 35,156 | $20.00 | $703.1K | 48,336 | Dec 17, 2021 | Dec 20, 2021 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE Chief Executive Officer | 35,156 | $10.90 | $383.2K | 83,492 | Dec 17, 2021 | Dec 20, 2021 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE Chief Executive Officer | 35,156 | — | — | 0 | Dec 17, 2021 | Dec 20, 2021 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE Chief Executive Officer | 50 | — | — | 0 | Sep 20, 2021 | Sep 20, 2021 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE Chief Executive Officer | 50 | $7.20 | $360 | 48,386 | Sep 20, 2021 | Sep 20, 2021 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE Chief Executive Officer | 50 | $20.00 | $1.0K | 48,336 | Sep 20, 2021 | Sep 20, 2021 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE Chief Executive Officer | 70,262 | — | — | 0 | Sep 17, 2021 | Sep 20, 2021 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE Chief Executive Officer | 70,262 | $20.07 | $1.41M | 48,336 | Sep 17, 2021 | Sep 20, 2021 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE Chief Executive Officer | 70,262 | $7.20 | $505.9K | 118,598 | Sep 17, 2021 | Sep 20, 2021 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASEGRANT Stock grant | 7,511 | — | — | 7,511 | Jun 8, 2021 | Jun 10, 2021 ↗ | View → |
| HOWL WEREWOLF THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 23,200 | — | — | 23,200 | Apr 30, 2021 | May 4, 2021 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE Chief Executive Officer | 35,156 | $20.55 | $722.4K | 48,336 | Feb 8, 2021 | Feb 10, 2021 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE Chief Executive Officer | 35,156 | — | — | 0 | Feb 8, 2021 | Feb 10, 2021 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE Chief Executive Officer | 35,156 | $7.20 | $253.1K | 83,492 | Feb 8, 2021 | Feb 10, 2021 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 195,000 | — | — | 195,000 | Feb 3, 2021 | Feb 5, 2021 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE Chief Executive Officer | 1,771 | $12.00 | $21.3K | 48,336 | Jan 31, 2021 | Feb 5, 2021 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE Chief Executive Officer | 17,466 | $20.06 | $350.3K | 46,565 | Nov 10, 2020 | Nov 12, 2020 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE Chief Executive Officer | 17,466 | $7.20 | $125.8K | 64,031 | Nov 10, 2020 | Nov 12, 2020 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE Chief Executive Officer | 17,466 | — | — | 0 | Nov 10, 2020 | Nov 12, 2020 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE Chief Executive Officer | 62,938 | $20.04 | $1.26M | 46,565 | Nov 9, 2020 | Nov 12, 2020 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE Chief Executive Officer | 62,938 | $7.20 | $453.2K | 109,503 | Nov 9, 2020 | Nov 12, 2020 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | SALE Chief Executive Officer | 62,938 | — | — | 0 | Nov 9, 2020 | Nov 12, 2020 ↗ | View → |
| NXTC NEXTCURE, INC. | PURCHASEGRANT Stock grant | 14,250 | — | — | 14,250 | Jun 11, 2020 | Jun 15, 2020 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASEGRANT Stock grant | 12,000 | — | — | 12,000 | Jun 3, 2020 | Jun 4, 2020 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASE | 2,500 | $38.18 | $95.5K | 29,520 | Mar 24, 2020 | Mar 25, 2020 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASEGRANT Stock grant | 194,000 | — | — | 194,000 | Feb 12, 2020 | Feb 14, 2020 ↗ | View → |
| SNDX SYNDAX PHARMACEUTICALS INC | PURCHASE Chief Executive Officer | 12,500 | $8.00 | $100.0K | 43,900 | Feb 4, 2020 | Feb 5, 2020 ↗ | View → |